Kiniksa Pharmaceuticals Ltd (KNSA) — Financial Flexibility Index
Kiniksa Pharmaceuticals Ltd (KNSA) has a Financial Flexibility Index of 0.20x as of June 2026. Free cash flow of $48.12 Million (operating CF $47.46 Million minus capex $663.00K) represents 0% of total liabilities ($241.96 Million). Check Kiniksa Pharmaceuticals Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kiniksa Pharmaceuticals Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Kiniksa Pharmaceuticals Ltd across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Kiniksa Pharmaceuticals Ltd.
Annual Financial Flexibility Index for Kiniksa Pharmaceuticals Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Kiniksa Pharmaceuticals Ltd. Explore Kiniksa Pharmaceuticals Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | $25.97 Million | $25.69 Million | $196.03 Million | ▼ -27.5% |
| 2024 | 0.18x | $25.97 Million | $25.69 Million | $142.12 Million | ▲ +19.0% |
| 2023 | 0.15x | $13.43 Million | $13.30 Million | $87.48 Million | ▲ +65.0% |
| 2022 | 0.09x | $5.91 Million | $5.81 Million | $63.52 Million | ▲ +104.2% |
| 2021 | -2.22x | $-105.88 Million | $-126.30 Million | $47.76 Million | ▲ +38.9% |
| 2020 | -3.63x | $-136.25 Million | $-136.53 Million | $37.53 Million | ▲ +31.9% |
| 2019 | -5.33x | $-155.17 Million | $-158.37 Million | $29.11 Million | ▼ -200.6% |
| 2018 | -1.77x | $-75.72 Million | $-81.01 Million | $42.70 Million | ▼ -385.2% |
| 2017 | -0.37x | $-50.15 Million | $-50.22 Million | $137.20 Million | ▼ -37.4% |
| 2016 | -0.27x | $-21.86 Million | $-21.87 Million | $82.20 Million | — |